삼성서울병원

Ko En

소화기내과 강원석 교수

진료분야
간암, 간경화, 급성간염, 만성간염, 지방간, 간이식, 간질환
진료일정 03 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후

학력

학력
2013.02 한국과학기술원(KAIST) 의과학대학원 박사
2009.02 연세대학교 의과대학 대학원 석사
2004.02 연세대학교 의과대학 의학과

경력

경력
2021.09 ~현재 성균관대학교 의과대학 내과학교실 부교수
2022.08 ~ 2023.07 The Jackson Laboratory for Genomic Medicine 연수
2016.03 ~ 2021.08 성균관대학교 의과대학 내과학교실 조교수
2015.09 ~ 2016.02 삼성서울병원 소화기내과 진료조교수
2015.03 ~ 2015.08 세브란스병원 연구조교수
2014.03 ~ 2015.02 세브란스병원 임상조교수
2013.05 ~ 2014.02 세브란스병원 임상강사
2013.03 ~ 2013.04 한국과학기술원 위촉연구원
2009.02 ~ 2013.02 한국과학기술원(KAIST) 전문연구요원
2005.03 ~ 2009.02 세브란스병원 레지던트
2004.03 ~ 2005.02 세브란스병원 인턴

학회활동

학회활동
2018.07 ~ 현재 대한간암학회 간암등록사업위원회 위원
2017.01 ~ 현재 대한소화기학회 학술위원회 위원
2015.11 ~ 현재 대한간학회 연구기획위원회 위원
  • J CLIN APHERESIS 2021 10.1002/jca.21873 Initial experience with high-volume plasma exchange in patients with acute liver failure Kim1, JE; Chun, S; Sinn, DH; Kim, NJ; Kim, S; Kang, W; Kim, JM; Choi, GS; Joh, JW; Cho, D
    View PubMed
  • EUR J CANCER 2021 10.1016/j.ejca.2021.03.024 Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study Park1, JH; Hong, JY; Kwon, M; Lee, J; Han, K; Han, IW; Kang, W; Park, JK
    View PubMed
  • J HEPATOCELL CARCINO 2021 10.2147/JHC.S304439 Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study Cho1, YY; Yu, SJ; Lee, HW; Kim, DY; Kang, W; Paik, YH; Sung, PS; Bae, SH; Park, SC; Doh, YS; Kim, KM; Jang, ES; Kim, IH; Kim, W; Kim, YJ
    View PubMed
  • NUTRIENTS 2021 10.3390/nu13031013 Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease Oh1, JH; Lee, JH; Cho, MS; Kim, H; Chun, J; Lee, JH; Yoon, Y; Kang, W
    View PubMed
  • DIGEST LIVER DIS 2021 10.1016/j.dld.2020.10.030 A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients Song1, BG; Kim, MJ; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J GASTROEN HEPATOL 2021 10.1111/jgh.15357 Metabolic activity assessment by F-18-fluorodeoxyglucose positron emission tomography in patients with hepatocellular carcinoma undergoing Yttrium-90 transarterial radioembolization Kim1, D; Lee, HW; Kang, W; Kim, GM; Won, JY; Yun, M
    View PubMed
  • LIVER CANCER 2021 10.1159/000512239 Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea Goh1, MJ; Oh, JH; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLIN MOL HEPATOL 2021 10.3350/cmh.2020.0095 Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study Yoo1, GS; Ahn, WG; Kim, SY; Kang, W; Choi, C; Park, HC
    View PubMed
  • CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2021 10.14309/ctg.0000000000000290 Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance Park1, Y; Lee, JH; Sinn, DH; Park, JY; Kim, MA; Kim, YJ; Yoon, JH; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • YONSEI MED J 2021 10.3349/ymj.2021.62.1.12 Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma Lee1, JS; Chon, YE; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Han, KH; Kang, W; Choi, MS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Kim, HY; Kim, TH; Yoo, K; Ha, Y; Kim, MN; Lee, JH; Hwang, SG; Kim, SS; Cho, HJ; Cheong, JY; Cho, SW; Park, SH; Heo, NY; Hong, YM; Yoon, KT; Cho, M; Park, JG; Kang, MK; Park, SY; Kweon, YO; Tak, WY; Jang, SY; Sinn, DH; Kim, SU
    View PubMed
  • SCAND J GASTROENTERO 2020 10.1080/00365521.2020.1866063 Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance potential implications for surveillance goal Song1, JH; Goh, MJ; Park, Y; Oh, JH; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLIN MOL HEPATOL 2020 10.3350/cmh.2020.0016 Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.4.238 Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria Oh1, JH; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, TW; Hyun, D; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • DIGEST DIS SCI 2020 10.1007/s10620-020-06591-x Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events Oh1, JH; Goh, MJ; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • DIGEST DIS SCI 2020 10.1007/s10620-020-06533-7 Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization A Nationwide, Multi-center, Retrospective Cohort Study Hyun1, HK; Cho, EJ; Park, SY; Hong, YM; Kim, SS; Kim, HY; Heo, NY; Park, JG; Sinn, DH; Kang, W; Jeong, SW; Song, MJ; Park, H; Lee, D; Lee, YS; Cho, SB; An, CS; Rhee, HJ; Lee, HW; Kim, BK; Park, JY; Kim, D; Ahn, SH; Han, KH; Lee, JH; Yu, SJ; Kim, YJ; Yoon, JH; Tak, WY; Kweon, YO; Yoon, KT; Cho, M; Cheong, JY; Park, SH; Kim, SU
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13279 Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients Kim1, J; Chung, SJ; Sinn, DH; Lee, KW; Park, JB; Huh, W; Lee, JE; Jang, HR; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • ALIMENT PHARM THER 2020 10.1111/apt.15741 Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase Lee1, HA; Lee, HW; Kim, IH; Park, SY; Sinn, DH; Yu, JH; Seo, YS; Um, SH; Lee, JI; Lee, KS; Lee, CH; Tak, WY; Kweon, YO; Kang, W; Paik, YH; Lee, JW; Suh, SJ; Jung, YK; Kim, BK; Park, JY; Kim, Y; Ahn, SH; Han, KH; Yim, HJ; Kim, SU
    View PubMed
  • TRANSPL P 2020 10.1016/j.transproceed.2020.01.037 Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma Song1, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Joh, JW; Choi, GS
    View PubMed
  • VIRUSES-BASEL 2020 10.3390/v12030302 The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses Shin1, EC; Han, JW; Kang, W; Kato, T; Kim, SJ; Zhong, J; Kim, S; Park, SH; Sung, PS; Watashi, K; Park, JY; Windisch, MP; Oh, JW; Wakita, T; Han, KH; Jang, SK
    View PubMed
  • J GASTROINTEST SURG 2020 10.1007/s11605-020-04540-7 Incidence of and Risk Factors for Alcohol Relapse After Liver Transplantation for Alcoholic Liver Disease: Comparison Between Deceased Donor and Living Donor Liver Transplantation Chung1, HG; Sinn, DH; Kang, W; Choi, GS; Kim, JM; Joh, JW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.040 Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.196 Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance Kim1, HK; Kang, W; Sinn, DH; Lee, JH; Kim, WS; Kim, SJ
    View PubMed
  • J GASTROEN HEPATOL 2019 10.1111/jgh.14750 Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0213547 Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment? Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0210730 Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
    View PubMed
  • STEM CELL RES THER 2019 10.1186/s13287-018-1127-3 The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis Park1, S; Hwang, SI; Kim, J; Hwang, S; Kang, S; Yang, S; Kim, J; Kang, W; Kim, KH; Han, DW; Paik, YH
    View PubMed
  • EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226 Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895 Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment? Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6 Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • CARDIOVASC INTER RAD 2017 10.1007/s00270-017-1751-9 Ultrasound-Guided Radiofrequency Ablation Using a New Electrode with an Electromagnetic Position Sensor for Hepatic Tumors Difficult to Place an Electrode: A Preliminary Clinical Study Kang1, TW; Lee, MW; Song, KD; Rhim, H; Lim, HK; Kang, W; Kim, K
    View PubMed
  • DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8 Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • HEPATOLOGY 2017 10.1002/hep.28916 Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment Kim1, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • GUT LIVER 2017 10.5009/gnl16403 A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels Sinn1, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients Kim JH11, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Dig Dis Sci. 2016 Nov;61(11):3354-3362. Epub 2016 Jul 19. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma Kim JH11, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • J Vasc Res. 2016;53(1-2):72-82. Epub 2016 Sep 20. Antiangiogenic Therapy Induces Hepatic Tumor Vascular Network Rearrangement to Receive Perfusion via the Portal Vein and Hepatic Artery Kang W11, Lim JS, Park MS, Koh GY, Kim H.
    View PubMed